National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 7062-7063 [2018-03186]

Download as PDF 7062 Federal Register / Vol. 83, No. 33 / Friday, February 16, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Healthy Start Initiative: Eliminating Disparities in Perinatal Health Program Listening Session Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: Listening Session: March 1, 2018, 1:00 p.m.–2:00 p.m. (EST). In addition, written comments will be accepted until March 16, 2018. ADDRESSES: The meeting will be held virtually via webinar and phone. The meeting is open to the public. Please register to attend this meeting via the following link: https://hrsa.connect solutions.com/healthy_start_ registration/event/registration.html. Registrations will be accepted through 5:00 p.m. EST on February 26, 2018. Call information for this meeting will be provided upon registration. SUPPLEMENTARY INFORMATION: The purpose of the meeting is to solicit ideas for program development in the next grant cycle of HRSA’s Healthy Start Initiative: Eliminating Disparities in Perinatal Health (Healthy Start) program, authorized by Section 330H of the Public Health Service Act (42 U.S.C. 254c–8), as amended by the Healthy Start Reauthorization Act of 2007 (Pub. L. 110–339). HRSA’s Healthy Start program currently supports 100 communitybased projects across the nation where the infant mortality rate (IMR) was more than 11⁄2 times the national average when they applied for funding. The program is designed to reduce IMR and improve perinatal health outcomes. Information about HRSA’s Healthy Start program can be obtained by accessing the following website: https:// mchb.hrsa.gov/maternal-child-healthinitiatives/healthy-start. The Healthy Start grants were last competed in fiscal year (FY) 2014 with a project period of up to 5 years. The next grant cycle is expected to begin in FY 2019 (subject to the availability of funding). The last Healthy Start funding opportunity announcement can be found here: https://apply07.grants.gov/apply/ opportunities/instructions/oppHRSA14-020-cfda93.926-cidHRSA-14-020instructions.pdf. The Listening Session will serve as a platform to engage and obtain feedback from the public on HRSA’s strategic thinking and approaches for daltland on DSKBBV9HB2PROD with NOTICES DATES: VerDate Sep<11>2014 19:24 Feb 15, 2018 Jkt 244001 community-based infant mortality reduction programs. A final meeting agenda will be shared with registrants prior to the meeting. The desired outcomes of the meeting are to: (1) Share with the public an overview of HRSA’s current Healthy Start program; (2) Identify strategies and approaches that are important to implement at the community level, and scientifically known to reduce infant mortality, improve perinatal outcomes, and disparities therein, through input from experts, representatives of professional organizations, and the public at large; and (3) Inform HRSA’s strategies and approaches implemented through the HRSA’s Healthy Start program. Time will be provided for public comments. Each public comment is limited to 2 minutes. During the meeting, participants will have an opportunity to interact with presenters via phone and the chat function in the public comment section of the webinar system. Telephone lines and time to provide oral comments during the meeting are available on a first-come, first-served basis. Registered attendees for this meeting are encouraged to submit written comments prior to the meeting, no later than 5:00 p.m. ET on February 26, 2018. If unable to attend the listening session, written comments will continue to be accepted via email to MCHBHealthyStart@hrsa.gov through March 16, 2018. All written comments should identify the individual’s name, address, email, telephone number, professional or organizational affiliation, background or area of expertise (i.e., program participant, clinician, public health worker, researcher, etc.), and topic/subject matter. Please note that all comments received under this notice will be made available to the general public upon written request, and are considered to be public, whether they are posted online or provided via written request. FOR FURTHER INFORMATION CONTACT: Individuals who are submitting public comments or who have questions regarding the meeting should contact Benita Baker or CAPT Maria Benke, HRSA, Maternal and Child Health Bureau, telephone: (301) 443–8283, or email: MCHBHealthyStart@hrsa.gov. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–03232 Filed 2–15–18; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01). Date: March 1, 2018. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Julio Aliberti, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC–9823, Rockville, MD 20852, 301–761–7322, alibertijc@ niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Clinical Trial Planning Grant (R34) and Implementation Cooperative Agreement (U01). Date: March 9, 2018. Time: 11:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Rm 3G42B, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9834, Bethesda, MD 20892–9834, (240) 669–5070, rosenthalla@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Division of Allergy, Immunology & Transplantation: ImmuneMediated Diseases Clinical Products Center. Date: March 12, 2018. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). E:\FR\FM\16FEN1.SGM 16FEN1 Federal Register / Vol. 83, No. 33 / Friday, February 16, 2018 / Notices Contact Person: Jay R. Radke, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3G11B, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC–9823, Bethesda, MD 20892–9823, (240) 669–5046, jay.radke@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 12, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–03186 Filed 2–15–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Coast Guard [Docket No. USCG–2018–0050] Towing Safety Advisory Committee U.S. Coast Guard, Department of Homeland Security. ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The Towing Safety Advisory Committee and its subcommittees will meet in Charleston, South Carolina to review and discuss recommendations from its subcommittees and to receive briefs on items listed in the agenda. All meetings will be open to the public. DATES: Meetings. The subcommittees of the Towing Safety Advisory Committee will meet on Tuesday, March 20, 2018 from 8 a.m. to 5 p.m. to conduct workgroup sessions. The full Committee will meet on Wednesday, March 21, 2018, from 8 a.m. to 5 p.m. These meetings may end early if the subcommittees or the Committee has completed its business, or the meetings may be extended based on the number of public comments. Comments and supporting documentation. To ensure your comments are reviewed by Committee members comment before the meetings, submit your written comments no later than March 6, 2018. ADDRESSES: All meetings will be held at the Charleston Marriott 170 Lockwood Boulevard, Charleston, South Carolina 29403; https://www.marriott.com/hotels/ travel/chsmc-charleston-marriott/. For information on facilities or services for individuals with disabilities, or to request special assistance at the meetings, contact the individuals listed in the FOR FURTHER daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:24 Feb 15, 2018 Jkt 244001 section as soon as possible. Written comments must be submitted using the Federal eRulemaking Portal at https://www.regulations.gov. If you encounter technical difficulties with comment submission, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section below. Instructions: You are free to submit comments at any time, including orally at the meetings, but if you want Committee members to review your comment before the meetings, please submit your comments no later than March 6, 2018. We are particularly interested in comments on the issues in the ‘‘Agenda’’ section below. You must include ‘‘Department of Homeland Security’’ and the docket number USCG–2018–0050. Comments received will be posted without alteration at https://www.regulations.gov, including any personal information provided. For more about privacy and the docket, review the Privacy and Security Notice for the Federal Docket Management System at https://www.regulations.gov/ privacyNotice. Docket Search: For access to the docket or to read documents or comments related to this notice, go to https://www.regulations.gov, insert USCG–2018–0050 in the Search box, press Enter, and then click on the item you wish to view. FOR FURTHER INFORMATION CONTACT: Commander Jose Perez, Designated Federal Officer of the Towing Safety Advisory Committee, Commandant (CG–OES–2), U.S. Coast Guard, 2703 Martin Luther King Jr. Avenue SE, Stop 7509, Washington, DC 20593–7509; telephone 202–372–1410, fax 202–372– 8382 or email jose.a.perez3@uscg.mil, or Mr. Kenneth Doyle, telephone 202–372– 1363 or email kenneth.j.doyle@uscg.mil. SUPPLEMENTARY INFORMATION: Notice of this meeting is in compliance with the Federal Advisory Committee Act, Title 5 United States Code Appendix. The Towing Safety Advisory Committee provides advice and recommendations to the Department of Homeland Security on matters relating to shallow-draft inland and coastal waterway navigation and towing safety. INFORMATION CONTACT Agenda of Meetings On March 20 and 21, 2018, from 8 a.m. to 5 p.m., the Towing Safety Advisory Committee and its subcommittees will meet to review, discuss, deliberate, and formulate recommendations, as appropriate, on the following tasks: • Subchapter M Implementation (Task 16–01) PO 00000 Frm 00056 Fmt 4703 Sfmt 9990 7063 • Inland Firefighting (Task 16–02) • Towing Liquefied Natural Gas Barges (Task 16–03) • Regulatory Reform (Task 17–01) • Load Line Exemption Review for River Barges on Lakes Erie and Ontario (Task 17–02) All current Towing Safety Advisory Committee tasks can be found at https:// homeport.uscg.mil/Lists/Content/ DispForm.aspx?&ID=574& Source=https://homeport.uscg.mil/ missions/ports-and-waterways/safetyadvisory-committees/tsac/ recommendations-reports. A copy of all meeting documentation, including any draft final reports, will be available at https://homeport.uscg.mil/ missions/ports-and-waterways/safetyadvisory-committees/tsac/ announcements no later than March 13, 2018. Alternatively, you may contact Mr. Kenneth Doyle as noted in the FOR FURTHER INFORMATION CONTACT section above. Public comments or questions will be taken throughout the meeting as the Committee discusses the issues and prior to deliberations and voting. There will also be a public comment period at the end of the meeting. Speakers are requested to limit their comments to 3 minutes. Please note that the public comment period may end before the period allotted, following the last call for comments. Please contact the individual listed in the FOR FURTHER INFORMATION CONTACT section above to register as a speaker. Notices of Future 2018 Towing Safety Advisory Committee Meetings To receive automatic email notices of future Towing Safety Advisory Committee meetings in 2018, go to the online docket, USCG–2018–0050 (https://www.regulations.gov/# !docketDetail;D=USCG-2018-0050), and select the Sign-up-for-Email-Alerts option. We plan to use the same docket number for all Towing Safety Advisory Committee meeting notices in 2018, so when the next meeting notice is published you will receive an email alert from https://www.regulations.gov when the notice appears in this docket, in addition to notices of other items being added to the docket. Dated: February 13, 2018. Jeffrey G. Lantz, Director of Commercial Regulations and Standards. [FR Doc. 2018–03221 Filed 2–15–18; 8:45 am] BILLING CODE 9110–04–P E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 83, Number 33 (Friday, February 16, 2018)]
[Notices]
[Pages 7062-7063]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03186]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Investigator Initiated Program 
Project Applications (P01).
    Date: March 1, 2018.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Julio Aliberti, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers 
Lane, MSC-9823, Rockville, MD 20852, 301-761-7322, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Clinical Trial Planning Grant 
(R34) and Implementation Cooperative Agreement (U01).
    Date: March 9, 2018.
    Time: 11:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Rm 3G42B, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5070, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Division of Allergy, 
Immunology & Transplantation: Immune-Mediated Diseases Clinical 
Products Center.
    Date: March 12, 2018.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).

[[Page 7063]]

    Contact Person: Jay R. Radke, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, Room 
#3G11B, National Institutes of Health, NIAID, 5601 Fishers Lane, 
MSC-9823, Bethesda, MD 20892-9823, (240) 669-5046, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 12, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-03186 Filed 2-15-18; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.